Civitas Resources CIVI 深 沪
等待开盘 12-18 09:30:00 美东时间
28.51
+1.710
+6.38%
华盛通- 最 高28.56
- 今 开27.26
- 成交量 151.55万股
- 最 低 27.14
- 昨 收 26.80
- 总市值 26.42亿
- 52周最高 53.35
- 市盈率 静 3.37
- 换手率 1.64%
- 52周最低 21.29
- 委 比 0.00%
- 总股本 9266.00万
- 历史最高 76.278
- 量 比 0.95
- 振 幅 5.30%
- 历史最低 21.29
- 每 手 1
- 风险率 7.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SM Energy declares $0.20 dividend
SM Energy (SM) declares $0.20/share quarterly dividend, in line with previous. Forward yield 4.38% Payable Jan. 9; for shareholders of record Dec. 26; ex-div Dec. 26. See SM Dividend Scorecard, Yield ...
12-17 05:19
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
12-15 15:30
UBS Maintains Neutral on Civitas Resources, Raises Price Target to $29
UBS analyst Josh Silverstein maintains Civitas Resources (NYSE:CIVI) with a Neutral and raises the price target from $27 to $29.
12-13 05:29
Shares of broader energy stocks are trading lower amid an overall market downturn as investors assess September jobs data, which could put a December rate cut into question.
Shares of broader energy stocks are trading lower amid an overall market downtu...
11-21 03:54
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
11-19 11:01
SM Energy Announces Merger Details with Civitas
An update from SM Energy ( ($SM) ) is now available. On November 17, 2025, SM E...
11-18 05:50
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
Oil and gas companies are trading higher amid optimism regarding the end of the ongoing U.S. government shutdown. Reports suggest that India has cut its December purchases of Russian crude oil due to pressure from sanctions and U.S. trade talks.
Oil and gas companies are trading higher amid optimism regarding the end of the...
11-12 01:55
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
